Stroke. 2009;40:e624-e626
Published online before print September 24, 2009,
doi: 10.1161/STROKEAHA.109.561928
(Stroke. 2009;40:e624.)
© 2009 American Heart Association, Inc.
Surgery for Primary Supratentorial Intracerebral Hematoma
A Meta-Analysis of 10 Randomized Controlled Trials
Kameshwar Prasad, MD, DM, MMSc, FRCP;
A. David Mendelow, MB, BCh, FRCS, PhD
Barbara Gregson, PhD
From the Department of Neurology (K.P.), All India Institute of Medical Sciences, New Delhi, India; and the Department of Neurosurgery (A.D.M., B.G.), Newcastle General Hospital, Newcastle-upon-Tyne, UK.
Correspondence to Dr Kameshwar Prasad, Professor, Department of Neurology, Room No. 704, Neurosciences Centre, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India. E-mail kprasad154@gmail.com
Graeme J. Hankey MD, FRCP Section Editor:
Key Words: intracranial hemorrhage meta-analysis surgery
An extract of the first 250 words of the full text is provided, because this article has no abstract.
|
 |
Introduction
|
|---|
There is considerable international variation in the rate and
indications of surgery for primary supratentorial intracerebral
hematoma (PSIH),
1,2 reflecting the uncertainty about the effects
of surgery. Recently, some large randomized trials have appeared
in the literature, but the controversy over its role continues.
3,4 This systematic review aims to evaluate randomized evidence
to assess the effects of surgery plus routine medical management,
compared with routine medical management alone, in patients
with PSIH.
 |
Methods
|
|---|
We searched the Cochrane Stroke Group Trials Register (up to
June 2007), monographs, and reference lists of relevant articles
and contacted authors of relevant trials. Studies were eligible
for inclusion if they were randomized trials of routine medical
management plus intracranianl surgery (includes craniotomy,
stereotactic, or endoscopic evacuation) compared with routine
medical management alone in patients with CT-confirmed PSIH.
Two review authors independently applied the inclusion criteria,
assessed trial quality, and extracted the data. We assessed
heterogeneity using
2 test and I
2. Meta-analysis was done using
fixed effects model with odds ratio as effect measure. Primary
and secondary outcomes were death or dependence (Barthel Index
of 60 or less) and death, respectively.
 |
Results
|
|---|
Ten trials with 2059 participants were included. The quality
of most of the trials was acceptable but not high. Surgery was
associated with statistically significant reduction in the odds
of being dead or dependent at final follow up (odds ratio [OR]
0.71, 95% confidence interval [CI] 0.58 to 0.88; 2
P=0.001; Figure 1)
with no significant heterogeneity (
P=0.22; I
2=24.7%) among the
study
. . . [Full Text of this Article]